Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2013 Oct 31;144PA:172–179. doi: 10.1016/j.jsbmb.2013.10.016

Figure 2. 25(OH)D3 suppresses monocyte migration in type 2 diabetics.

Figure 2

Transwell migration assays in monocytes from vitamin D-deficient type 2 diabetics cultured in A. vitamin D-deficient or 25(OH)D3-treated patient serum (n=12, *p<0.001 vs. vitamin D-deficient) and B. vitamin D-deficient or 25(OH)D3-treated media (n=12, *p<0.005 vs. vitamin D-deficient). C–D. qPCR for mRNA of CCR2 from monocytes from vitamin D-deficient type 2 diabetics cultured inC. vitamin D-deficient or 25(OH)D3-treated patient serum and D. vitamin D-deficient or 25(OH)D3-treated media (n=6, *p<0.001 for both vs. vitamin D-deficient).